Finoriq

Finoriq research workspace

AdaptHealth Corp. (AHCO) Historical Metrics

AdaptHealth Corp. distributes home medical equipment (HME), medical supplies, and home and related. Review AHCO fundamentals, ratios, and historical filing metrics on Finoriq.

Company Snapshot

AdaptHealth Corp., together with its subsidiaries, distributes home medical equipment (HME), medical supplies, and home and related services in the United States. It operates through Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home segments. The company offers sleep therapy equipment, supplies, and related services, such as continuous positive airway pressure and BiLevel services to individuals suffering from obstructive sleep apnea; oxygen and home mechanical ventilation equipment and supplies and related chronic therapy services; and medical devices, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; and other HME devices and supplies. It also provides PAP machines, wheelchairs, hospital beds, oxygen concentrators, ventilators, insulin pumps, diabetes management and wound care supplies, orthopedic bracing, breast pumps and supplies, walkers, commodes, enteral supplies, and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. was founded in 2012 and is headquartered in Conshohocken, Pennsylvania.

Company
AdaptHealth Corp. (AHCO)
Ticker
AHCO
Market Cap
$1.5B
Latest Price
$11.19
Industry
Health Care Services

Open insider transactions

AdaptHealth Corp. (AHCO) Current Valuation Metrics

Static valuation preview for AdaptHealth Corp. (AHCO). Market data retrieved 2026-07-08. Filing currency USD.

MetricValueSource
P/SMarket cap divided by latest TTM revenue.0.42xRevenue | TTM Q1 2026
P/Operating Cash FlowMarket cap divided by latest TTM operating cash flow.2.28xOperating Cash Flow | TTM Q1 2026
Earnings YieldLatest TTM net income divided by market cap.-5.8%Net Income | TTM Q1 2026
Operating Cash Flow YieldLatest TTM operating cash flow divided by market cap.43.9%Operating Cash Flow | TTM Q1 2026
Price / BookMarket cap divided by stockholders' equity.0.91xStockholders' Equity | Q1 2026

Live data loads in the app

This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.